|
Volumn 1, Issue 1, 2004, Pages 10-11
|
Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
|
Author keywords
Cardiac resynchronization therapy; Chronic heart failure; Pacemaker; Pacemaker defibrillator
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
SPIRONOLACTONE;
CARDIAC RESYNCHRONIZATION THERAPY;
CARDIOMYOPATHY;
CLINICAL TRIAL;
DEFIBRILLATOR;
DISEASE CLASSIFICATION;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART MUSCLE ISCHEMIA;
HOSPITALIZATION;
HUMAN;
MORTALITY;
PR INTERVAL;
PRIORITY JOURNAL;
QRS COMPLEX;
RISK REDUCTION;
SHORT SURVEY;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CARDIAC PACING, ARTIFICIAL;
DIURETICS;
DRUG THERAPY, COMBINATION;
ELECTRIC COUNTERSHOCK;
FOLLOW-UP STUDIES;
HEART FAILURE, CONGESTIVE;
HOSPITALIZATION;
HUMANS;
STROKE VOLUME;
SURVIVAL RATE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 20444504700
PISSN: 17434297
EISSN: None
Source Type: Journal
DOI: 10.1038/ncpcardio0005 Document Type: Short Survey |
Times cited : (5)
|
References (5)
|